Odylia utilizes a unique, nonprofit business model to accelerate the development of gene therapies for people with rare disease, changing the way treatments are brought from the lab to the clinic. Our ultimate goal is to bring life changing treatments to people with genetic disease regardless of prevalence or commercial interest.